WAZ Stock Chart & Stats
€328.80
-€7.80(-2.32%)
At close: 4:00 PM EDT
€328.80
-€7.80(-2.32%)
Day’s Range― - ―
52-Week Range€235.00 - €352.50
Previous CloseN/A
Volume0.00
Average Volume (3M)9.00
Market Cap
€32.12B
Enterprise Value€30.10K
Total Cash (Recent Filing)€462.00M
Total Debt (Recent Filing)€5.57B
Price to Earnings (P/E)47.9
Beta0.40
Next Earnings
Aug 04, 2026EPS Estimate
2.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.88
Shares Outstanding98,185,850
10 Day Avg. Volume3
30 Day Avg. Volume9
Financial Highlights & Ratios
PEG Ratio75.61
Price to Book (P/B)8.83
Price to Sales (P/S)7.14
P/FCF Ratio41.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€349.61Price Target Upside6.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)12.62
Revenue Forecast (FY)€5.59B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & Services RevenueWaters' installed‑base model yields recurring consumables, service contracts and software support that generate higher‑frequency, sticky revenue. This reduces topline cyclicality from capital equipment, supports margin mix, and creates customer lock‑in over multiple years.
Re‑accelerating Top‑line / Organic GrowthMaterial re‑acceleration in organic growth and strong combined‑company Q1 sales indicate recovering instrument demand and early cross‑sell lift from acquisitions. Durable revenue momentum across legacy and acquired businesses supports scale economics and reinvestment capacity over the medium term.
Clear Synergy Targets And Integration PlanConcrete synergy targets, a 180‑day integration plan and raised guidance indicate disciplined M&A execution. Realized cost and revenue synergies can structurally lift margins and free cash flow once implemented, improving long‑term earnings quality and integration returns.
Bears Say
Sharp Margin Compression And Lower ReturnsA near 1,000bp step‑down in net margin and ROE compression to ~8% reflect weakened earnings quality after acquisition accounting, mix shifts or cost pressure. Persistently lower margins reduce cash available for reinvestment and make future ROE recovery dependent on successful synergies and pricing discipline.
Weakened Cash Generation / FCF DeclineA more than 50% decline in FCF and sub‑par cash conversion materially reduce financial flexibility. Lower FCF constrains debt reduction, capital expenditure, and funding for integration costs or shareholder returns absent external financing, making execution risk on synergies more consequential.
Geographic/regulatory And Instrument Demand HeadwindsExport restrictions, China DRG impacts and weak respiratory testing create structural regional and regulatory risks. Persistent localization needs and uneven instrument recovery (academic/government pressure) can dampen growth and complicate margin recovery in sizable end markets over multiple quarters.
WAZ FAQ
What was Waters Corp.’s price range in the past 12 months?
Waters Corp. lowest stock price was €235.00 and its highest was €352.50 in the past 12 months.
What is Waters Corp.’s market cap?
Waters Corp.’s market cap is €32.12B.
When is Waters Corp.’s upcoming earnings report date?
Waters Corp.’s upcoming earnings report date is Aug 04, 2026 which is today.
How were Waters Corp.’s earnings last quarter?
Waters Corp. released its earnings results on May 05, 2026. The company reported €2.341 earnings per share for the quarter, beating the consensus estimate of €2 by €0.341.
Is Waters Corp. overvalued?
According to Wall Street analysts Waters Corp.’s price is currently Undervalued.
Does Waters Corp. pay dividends?
Waters Corp. does not currently pay dividends.
What is Waters Corp.’s EPS estimate?
Waters Corp.’s EPS estimate is 2.61.
How many shares outstanding does Waters Corp. have?
Waters Corp. has 98,185,850 shares outstanding.
What happened to Waters Corp.’s price movement after its last earnings report?
Waters Corp. reported an EPS of €2.341 in its last earnings report, beating expectations of €2. Following the earnings report the stock price went up 10.599%.
Which hedge fund is a major shareholder of Waters Corp.?
Currently, no hedge funds are holding shares in DE:WAZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Waters Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€349.61 (6.33% Upside)
€349.61 (6.33% Upside)
Blogger Sentiment
Bullish
DE:WAZ Sentiment 80%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.53%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
434.26%
Trailing 12-Months
Company Description
Waters Corp.
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
WAZ Company Deck
WAZ Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive picture: strong combined‑company Q1 results with double‑digit organic growth in legacy businesses, a meaningful EPS beat (+20%), margin outperformance, an above‑plan start for the acquired BD businesses, and raised full‑year guidance. Management also outlined concrete integration actions (180‑day plan), product/regulatory wins, and synergy targets with clear timelines. Offsetting risks include a $20M respiratory headwind, notable China DRG and export constraints that drove declines in parts of the acquired businesses, Q1 GAAP acquisition‑related charges and modest free cash flow impacted by transaction costs, and prudent conservatism baked into the back‑half guide. Overall the positives—beats, raised guidance, tangible synergy progress and product/regulatory milestones—materially outweigh the near‑term operational and geographic headwinds.View all DE:WAZ earnings summariesWAZ Revenue Breakdown
34.81% Waters instrument systems
19.95% Chemistry consumables
34.13% Waters service
7.70% TA instrument systems
3.41% TA service

WAZ Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€349.61
▲(6.33% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month









